Psychiatry Research
Volume 157, Issue 1 , Pages 87-93 , 15 January 2008

Essential polyunsaturated fatty acids and social cognition in schizophrenia

  • Tomiki Sumiyoshi

      Affiliations

    • Department of Neuropsychiatry, University of Toyama School of Medicine, 2630 Sugitani, Toyama 930-0194, Japan
    • Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Department of Neuropsychiatry, University of Toyama School of Medicine, 2630 Sugitani, Toyama 930-0194, Japan. Tel.: +81 76 434 7323; fax: +81 76 434 5030.
    • ,
  • Mie Matsui

      Affiliations

    • Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Tokyo, Japan
    • Departmenf of Psychology, University of Toyama School of Medicine, Toyama, Japan
    • ,
  • Hiroko Itoh

      Affiliations

    • Department of Neuropsychiatry, University of Toyama School of Medicine, 2630 Sugitani, Toyama 930-0194, Japan
    • ,
  • Yuko Higuchi

      Affiliations

    • Department of Neuropsychiatry, University of Toyama School of Medicine, 2630 Sugitani, Toyama 930-0194, Japan
    • ,
  • Hirofumi Arai

      Affiliations

    • Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Tokyo, Japan
    • Departmenf of Psychology, University of Toyama School of Medicine, Toyama, Japan
    • ,
  • Chieko Takamiya

      Affiliations

    • Departmenf of Psychology, University of Toyama School of Medicine, Toyama, Japan
    • ,
  • Masayoshi Kurachi

      Affiliations

    • Department of Neuropsychiatry, University of Toyama School of Medicine, 2630 Sugitani, Toyama 930-0194, Japan
    • Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Tokyo, Japan

Received 24 January 2006 ,Revised 11 April 2006 ,Accepted 25 May 2006.

References 

  1. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research. 2003;62:195–204
  2. Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry. 2003;53:56–64
  3. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biological Psychiatry. 2001;49:510–522
  4. Chan AS, Chiu H, Lam L, Pang A, Chow LY. A breakdown of event schemas in patients with schizophrenia: an examination of their script for dining at restaurants. Psychiatry Research. 1999;87:169–181
  5. Connor WE, Neuringer M, Lin DS. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. Journal of Lipid Research. 1990;31:237–247
  6. Crozier S, Sirigu A, Lehericy S, van de Moortele PF, Pillon B, Grafman J, et al. Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study. Neuropsychologia. 1999;37:1469–1476
  7. Doris AB, Wahle K, MacDonald A, Morris S, Coffey I, Muir W, et al. Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia. Schizophrenia Research. 1998;31:185–196
  8. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biological Psychiatry. 2000;47:8–21
  9. Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. British Journal of Psychiatry. 2002;181:22–28
  10. Glen AI, Glen EM, Horrobin DF, Vaddadi KS, Spellman M, Morse-Fisher N, et al. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophrenia Research. 1994;12:53–61
  11. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research. 2004;72:41–51
  12. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Research. 1998;30:193–208
  13. Keefe RS, Eesley CE, Poe MP. Defining a cognitive function decrement in schizophrenia. Biological Psychiatry. 2005;57:688–691
  14. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research. 2002;58:1–10
  15. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders. 1996;38:35–46
  16. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research. 1999;85:275–291
  17. Matsui, M., Yuuki, H., Kato, K., Kurachi, M., in press. Impairment of memory organization in patients with schizophrenia or schizotypal disorder. Journal of International Neuropsychology Society.
  18. Matsui M, Sumiyoshi T, Kato K, Yoneyama E, Kurachi M. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia. Psychological Reports. 2004;94:387–397
  19. Matsui M, Sumiyoshi T, Yuuki H, Kato K, Kurachi M. Impairment of event schema in patients with schizophrenia: examination of script for shopping at supermarket. Psychiatry Research. 2006;143(2–3):179–187
  20. Nohara S, Suzuki M, Kurachi M, Yamashita I, Matsui M, Seto H, et al. Neural correlates of memory organization deficits in schizophrenia: a single photon emission computed tomography study with 99m-Tc-ethyl-cysteinate dimmer during a verbal learning task. Schizophrenia Research. 2000;42:209–222
  21. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports. 1962;10:799–812
  22. Peet M, Horrobin DF. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. Journal of Psychiatric Research. 2002;36:7–18
  23. Peet M, Laugharne J, Rangarajan N, Horrobin D, Reynolds G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. Journal of Psychiatric Research. 1995;29:227–232
  24. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research. 2003;121:109–122
  25. Reddy RD, Keshavan MS, Yao JK. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophrenia Bulletin. 2004;30:901–911
  26. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Archives of General Psychiatry. 1991;48:618–624
  27. Sumiyoshi C, Matsui M, Sumiyoshi T, Yamashita I, Sumiyoshi S, Kurachi M. Semantic structure in schizophrenia as assessed by the category fluency test: effect of verbal intelligence and age of onset. Psychiatry Research. 2001;105:187–199
  28. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, et al. The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia. Biological Psychiatry. 2001;49:861–868
  29. Sumiyoshi C, Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, et al. Effect of orthography on the verbal fluency performance in schizophrenia: examination using Japanese patients. Schizophrenia Research. 2004;69:15–22
  30. Sumiyoshi C, Sumiyoshi T, Nohara S, Yamashita I, Matsui M, Kurachi M, et al. Disorganization of semantic memory underlies alogia in schizophrenia: an analysis of verbal fluency performance in Japanese subjects. Schizophrenia Research. 2005;74:91–100
  31. Vaddadi KS, Courtney P, Gilleard CJ, Manku MS, Horrobin DF. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Research. 1989;27:313–323
  32. Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2001;65:1–7
  33. Wainwright PE. Do essential fatty acids play a role in brain and behavioral development?. Neuroscience and Biobehavioral Reviews. 1992;16:193–205
  34. Yao JK, van Kammen DP. Red blood cell membrane dynamics in schizophrenia: I. Membrane fluidity. Schizophrenia Research. 1994;11:209–216
  35. Yao JK, van Kammen DP, Gurklis J. Red blood cell membrane dynamics in schizophrenia: III. Correlation of fatty acid abnormalities with clinical measures. Schizophrenia Research. 1994;13:227–232
  36. Yao JK, van Kammen DP, Welker JA. Red blood cell membrane dynamics in schizophrenia: II. Fatty acid composition. Schizophrenia Research. 1994;13:217–226
  37. Zanarini MC, Frankenburg FR. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry. 2003;160:167–169

PII: S0165-1781(06)00192-2

doi: 10.1016/j.psychres.2006.05.025

Psychiatry Research
Volume 157, Issue 1 , Pages 87-93 , 15 January 2008

Article Tools

* Image Usage & Resolution